The pandemic of acute respiratory disease in 2019 caused by highly pathogenic and infectious SARS-CoV-2 has seriously endangered human public safety. The 6-HB (HR1–HR2 complex) formation occurring in

NIAID Data Ecosystem50

Discovery of the Clinical Candidate S‑892216: A Second-Generation of SARS-CoV‑2 3CL Protease Inhibitor for Treating COVID-19

COVID-19

3CL蛋白酶抑制剂

The coronavirus disease 2019 (COVID-19) pandemic crisis has been mitigated by worldwide efforts to develop vaccines and therapeutic drugs. However, there remains concern regarding public health and an

Figshare2025-07-05 更新30

Crystal structure of SARS-CoV-2 3CL protease (3CLpro) in complex with compound 51

资源简介：

相关数据集